Estradiol cyclooctyl acetate
Estradiol cyclooctyl acetate (E2COA) is a synthetic, steroidal estrogen and an estrogen ester – specifically, the C17β cyclooctyl ester of estradiol. It is a prodrug of estradiol and has been studied for use in hormone replacement therapy.
Chemical Structure[edit | edit source]
Estradiol cyclooctyl acetate is a derivative of estradiol, a naturally occurring estrogen hormone. The chemical structure of E2COA includes the cyclooctyl ester at the C17β position of the estradiol molecule. This modification is intended to enhance the pharmacokinetic properties of estradiol, such as its bioavailability and half-life.
Pharmacology[edit | edit source]
As a prodrug of estradiol, E2COA is metabolized in the body to release active estradiol. This process allows for a more controlled and sustained release of the hormone, which can be beneficial in hormone replacement therapy for conditions such as menopause and hypoestrogenism. The pharmacological effects of E2COA are primarily due to its conversion to estradiol, which then exerts its effects by binding to estrogen receptors in various tissues.
Medical Uses[edit | edit source]
Estradiol cyclooctyl acetate has been investigated for its potential use in hormone replacement therapy to alleviate symptoms associated with menopause, such as hot flashes, vaginal atrophy, and osteoporosis. It may also be used in the treatment of hypoestrogenism due to various causes, including ovarian failure and hypogonadism.
Administration[edit | edit source]
E2COA can be administered via various routes, including oral administration, intramuscular injection, and transdermal delivery. The choice of administration route depends on the desired pharmacokinetic profile and patient preference.
Side Effects[edit | edit source]
As with other estrogen therapies, the use of estradiol cyclooctyl acetate may be associated with side effects such as nausea, breast tenderness, headache, and an increased risk of thromboembolic events. Long-term use of estrogen therapy may also be associated with an increased risk of endometrial cancer and breast cancer.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
-
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD